Vivo Capital, LLC Revolution Medicines, Inc. Transaction History

Vivo Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$37.21 - $54.43 $621,034 - $908,436	-16,690 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$30.19 - $45.49 $2.5 Million - $3.77 Million	-82,827 Reduced 83.23%	16,690 $661,000
Q3 2020 Nov 13, 2020	SELL	$22.61 - $34.8 $2.26 Million - $3.48 Million	-100,001 Reduced 50.12%	99,517 $3.46 Million
Q1 2020 May 15, 2020	BUY	$20.0 - $34.08 $3.99 Million - $6.8 Million	199,518 New	199,518 $4.37 Million

273

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.5B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.